Telemetry Investments’s Fresh Tracks Therapeutics, Inc. Common Stock FRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q4
$95K Sell
65,000
-1,000
-2% -$1.46K 0.15% 86
2022
Q3
$118K Buy
66,000
+41,889
+174% +$74.9K 0.15% 110
2022
Q2
$137K Sell
24,111
-18,225
-43% -$104K 0.16% 115
2022
Q1
$510K Sell
42,336
-13,952
-25% -$168K 0.8% 46
2021
Q4
$580K Buy
56,288
+40,747
+262% +$420K 0.75% 43
2021
Q3
$504K Buy
15,541
+1,986
+15% +$64.4K 0.68% 47
2021
Q2
$580K Buy
13,555
+2,159
+19% +$92.4K 0.8% 47
2021
Q1
$559K Buy
11,396
+7,043
+162% +$345K 0.63% 61
2020
Q4
$153K Buy
+4,353
New +$153K 0.26% 80